Suma Krishnan
CIK 1298711 · President, R&D · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$487.95M
Companies
3
Total Filings
55
Lifetime Open-Market Net
-$125.35M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KRYS | President, R&D | 1,430,434 | $341.12 | $487.95M | -$124.60M | 37 | 2026-06-05 |
| PRECIGEN, INC. (XON) Delisted | SVP--Product Development | 113,314 | — | — | -$745.4K | 4 | 2016-02-01 |
| NEW RIVER PHARMACEUTICALS INC (NRPH) Delisted | Vice President, Product Dev. | — | — | — | $0 | 1 | 2007-01-31 |
Recent Filings · Page 3 of 6
55 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-11 | KRYS | Sell (S) | −50,000 | -$8.55M | EDGAR |
| 2024-03-01 | KRYS | Mixed | +10,744 | -$1.51M | EDGAR |
| 2024-02-28 | KRYS | Tax (F) | −2,353 | -$369.4K | EDGAR |
| 2023-12-12 | KRYS | Sell (S) | −50,000 | -$5.28M | EDGAR |
| 2023-12-11 | KRYS | Notice (144) | −25,000 | -$2.67M | EDGAR |
| 2023-09-12 | KRYS | Sell (S) | −50,000 | -$6.36M | EDGAR |
| 2023-09-11 | KRYS | Notice (144) | −25,000 | -$3.10M | EDGAR |
| 2023-06-02 | KRYS | Sell (S) | −50,000 | -$5.81M | EDGAR |
| 2023-05-31 | KRYS | Notice (144) | −25,000 | -$2.90M | EDGAR |
| 2023-04-18 | KRYS | Sell (S) | −50,000 | -$4.38M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.